In accordance with the Ministry of Food and Drug Safety's 'Drug Approval Change Order' (Drug Management Division-No. 7209, effective date July 29, 2014), precautions for the use of Repoxin tablets have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Lefoxin Tab.
Attachments are original documents and may be in Korean. English editions are labeled separately.
Precautions for use_Levofloxacin_1.hwpPrecautions for use_Levofloxacin_1.hwp · 46 KBDownload ↓